THE BUSINESS OF BIOTECH
Physician + Biotech Builder with Tome Biosciences' Rahul Kakkar, M.D.
Novel technologies aren’t interesting to Rahul Kakkar, M.D. unless they help patients. Sounds rational, but it’s actually a unique perspective in a platform-crazed biotech industry. Dr. Kakkar’s worldview is shaped by his work as a physician—work he continues at Brigham and Women’s Hospital even as he builds Tome Biosciences, where he serves as President & CEO.
ABOUT THE BUSINESS OF BIOTECH
Created exclusively for the leaders of new and emerging biopharma firms, The Business of Biotech tackles organizational, funding, HR, regulatory, production and CMC considerations with insight from peer founders who have taken biologic therapies from an idea to clinical success.
FEATURED GUESTS
Rahul Kakkar
Bobby Reddy
Jason Gardner
Karen Harris
Michael Nally
Gavin Samuels
Robert Williamson
Brian Finrow
Jack Hoppin
Guillaume Pfefer
MEET THE HOST
Hosted by Bioprocess Online Chief Editor Matt Pillar, The Business of Biotech brings you weekly intelligence and insight, from leading voices in the biotech industry.
Interested in joining us on air ? Contact us
RECENT EPISODES
Physician + Biotech Builder with Tome Biosciences' Rahul Kakkar, M.D.
Commercial Readiness with ImmunityBio's Bobby Reddy, M.D.
Precision Drug Delivery with Ampersand Biomedicines' Jason Gardner, Ph.D.
The Innovator's Dilemma with Lumen Bioscience's Brian Finrow, J.D.
Precision Radiopharmaceuticals with Ratio's Jack Hoppin, Ph.D.
FINANCE & CAPITAL MARKETS
Surviving The Microbiome Market with MaaT Pharma's Hervé Affagard
BoB@JPM: Post-IPO With Bolt Biotherapeutics' Drs. Randall Schatzman and Edith Perez
Lessons From The Bone Therapeutics/Medsenic Merger With BioSenic's François Rieger, Ph.D.
Athersys' Ivor Macleod On Bringing Big-League Financial Experience To An Emerging Biotech
DISCOVERY
Gene Therapies For Ocular Disease With SparingVision's Stéphane Boissel
REGULATORY
What's Next For COVID Vaccines With Tonix Pharmaceuticals' Seth Lederman, M.D.
Dissecting Spesolimab's Approval With Boehringer Ingelheim's Carine Boustany
How To Apply For BTD And Win It With Drs. Ira Gupta & Shanthi Ganeshan
MANUFACTURING
Product Vs. Platform With Surface's Vito Palombella, Ph.D. And Robert Ross, M.D.
mAb Manufacturing with Rezolute Bio's Nevan Charles Elam, JD
Women In Biotech With Bill & Melinda Gates MRI's Piper Trelstad, Ph.D.
Gene Therapy Manufacturing At-Scale With Geoff MacKay
Inhalable mRNA With Ethris' Carsten Rudolph, Ph.D.
Complete CAR T Manufacturing Control with Cellectis' Steve Doares
NK Cell Therapy Accessibility With Shoreline Biosciences' Dr. Kleanthis Xanthopoulos
Building LEO Pharma's U.S. Presence with Brian Hilberdink
In-Vivo CAR T Update With Umoja Biopharma's David Fontana, Ph.D.